Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

Visepegenatide

A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of PB-119 Injection in Chinese Obese Subjects

PegBio Co · Phase 1/2 · Completed · Enrollment 32

NCT06350812

ArmPopulationDoseWeeksEstimandWeight change
PB-119Obesity or overweightn/r1n/rn/r
PlaceboObesity or overweightn/r1n/rn/r